Assessment of treatment-related myelodysplastic syndromes (tMDS) and acute myeloid leukemia (tAML) in patients with low-grade non-Hodgkin's lymphoma (LG-NHL) treated with tositumomab and iodine-131 tositumomab (the BEXXAR (R) therapeutic regimen). Bennett, J. M., Kaminski, M. S., Knox, S. J., Zelenetz, A. D., Leonard, J. P., Vose, J. M., Horning, S. AMER SOC HEMATOLOGY. 2003: 30A

View details for Web of Science ID 000186536700092